PUBLISHER: IMARC | PRODUCT CODE: 1675366
PUBLISHER: IMARC | PRODUCT CODE: 1675366
The global osteosynthesis devices market size reached USD 10.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 17.4 Billion by 2033, exhibiting a growth rate (CAGR) of 5.67% during 2025-2033. The increasing incidences of road accidents across the globe and the rising prevalence of bone fractures and osteoarthritis, especially amongst the geriatric population, represent some of the key factors driving the market.
Osteosynthesis represents a reconstructive orthopedic surgical procedure intended to join and stabilize various broken and fractured bone fragments by using multiple implantable devices, screws, plates, spinal fixations, and intramedullary rods. It encompasses bone lengthening and Ilizarov devices, washers, Kirschner wires (K-wires), fracture fixation solutions, and other medical implants as standard internal and external product types that are commonly used in surgeries. These components are manufactured from several degradable and non-degradable materials, including magnesium, titanium, zinc, iron, metallic alloys, polymers, glasses, and ceramics. Osteosynthesis devices aid in increasing the contact surface between the implants and osteoporotic bone, correcting the bone position, and healing the damages while providing optimal stability and providing better clinical outcomes. As a result, osteosynthesis devices are used in the treatment of hip, femur, hand, wrist, clavicle, scapula, patella, and fibula fractures.
The increasing incidences of road accidents across the globe represents one of the primary factors driving the market growth. Moreover, the rising prevalence of bone fractures and osteoarthritis, especially amongst the geriatric population is contributing to the market growth. In line with this, the rising need for bone surgeries and the shifting consumer inclination toward minimally invasive operations over full-fledged surgical procedures due to their multiple benefits are acting as another growth-inducing factor. This is primarily because minimally invasive surgeries help achieve better results, reduce the risk of infection, avoid large-scale blood loss, mitigate skin and tissues caused by incisions and offer better clinical outcomes. Additionally, the favorable initiatives being implemented by governments of numerous countries to invest in biomedical companies for manufacturing several osteosynthesis devices for diverse body parts are supporting the market growth. Furthermore, the extensive utilization of biocompatible and bioabsorbable materials to fabricate plates, rods, wires, pins, and screws is favoring the market growth. These components offer various advantages, including eliminating the need to remove osteosynthesis devices and ensuring faster bone healing. Other factors, such as significant enhancements in the healthcare infrastructures and the continuous research and development (R&D) activities in the field of medical sciences to enhance the efficacy of osteosynthesis devices, are creating a positive outlook for the market.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.